Association of genetic variation in genes implicated in the β-catenin destruction complex with risk of breast cancer

Xianshu Wang, Ellen L Goode, Zachary S. Fredericksen, Robert A. Vierkant, V. Shane Pankratz, Wen Liu-Mares, David N. Rider, Celine M Vachon, James R Cerhan, Janet E Olson, Fergus J Couch

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Aberrant Wnt/β-catenin signaling leading to nuclear accumulation of the oncogene product β-catenin is observed in a wide spectrum of human malignancies. The destruction complex in the Wnt/β-catenin pathway is critical for regulating the level of β-catenin in the cytoplasm and in the nucleus. Here, we report a comprehensive study of the contribution of genetic variation in six genes encoding the β-catenin destruction complex (APC, AXIN1, AXIN2, CSNK1D, CSNK1E, and GSK3B) to breast cancer using a Mayo Clinic Breast Cancer Case-Control Study. A total of 79 candidate functional and tagging single nucleotide polymorphisms (SNP) were genotyped in 798 invasive cases and 843 unaffected controls. Of these, rs454886 in the APC tumor suppressor gene was associated with increased breast cancer risk (per allele odds ratio, 1.23; 95% confidence intervals, 1.05-1.43; Ptrend = 0.01). In addition, five SNPs in AXIN2 were associated with increased risk of breast cancer (P trend < 0.05). Haplotype-based tests identified significant associations between specific haplotypes in APC and AXIN2 (P ≤ 0.03) and breast cancer risk. Further characterization of the APC and AXIN2 variants suggested that AXIN2 rs4791171 was significantly associated with risk in premenopausal (Ptrend = 0.0002) but not in postmenopausal women. The combination of our findings and numerous genetic and functional studies showing that APC and AXIN2 perform crucial tumor suppressor functions suggest that further investigation of the contribution of AXIN2 and APC SNPs to breast cancer risk are needed.

Original languageEnglish (US)
Pages (from-to)2101-2108
Number of pages8
JournalCancer Epidemiology Biomarkers and Prevention
Volume17
Issue number8
DOIs
StatePublished - Aug 2008

Fingerprint

Catenins
Breast Neoplasms
Genes
Single Nucleotide Polymorphism
Haplotypes
Wnt Signaling Pathway
Oncogene Proteins
Tumor Suppressor Genes
Case-Control Studies
Neoplasms
Cytoplasm
Alleles
Odds Ratio
Confidence Intervals

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Association of genetic variation in genes implicated in the β-catenin destruction complex with risk of breast cancer. / Wang, Xianshu; Goode, Ellen L; Fredericksen, Zachary S.; Vierkant, Robert A.; Pankratz, V. Shane; Liu-Mares, Wen; Rider, David N.; Vachon, Celine M; Cerhan, James R; Olson, Janet E; Couch, Fergus J.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 17, No. 8, 08.2008, p. 2101-2108.

Research output: Contribution to journalArticle

@article{fbfb5f1ed66943a5a7b11de3bb162238,
title = "Association of genetic variation in genes implicated in the β-catenin destruction complex with risk of breast cancer",
abstract = "Aberrant Wnt/β-catenin signaling leading to nuclear accumulation of the oncogene product β-catenin is observed in a wide spectrum of human malignancies. The destruction complex in the Wnt/β-catenin pathway is critical for regulating the level of β-catenin in the cytoplasm and in the nucleus. Here, we report a comprehensive study of the contribution of genetic variation in six genes encoding the β-catenin destruction complex (APC, AXIN1, AXIN2, CSNK1D, CSNK1E, and GSK3B) to breast cancer using a Mayo Clinic Breast Cancer Case-Control Study. A total of 79 candidate functional and tagging single nucleotide polymorphisms (SNP) were genotyped in 798 invasive cases and 843 unaffected controls. Of these, rs454886 in the APC tumor suppressor gene was associated with increased breast cancer risk (per allele odds ratio, 1.23; 95{\%} confidence intervals, 1.05-1.43; Ptrend = 0.01). In addition, five SNPs in AXIN2 were associated with increased risk of breast cancer (P trend < 0.05). Haplotype-based tests identified significant associations between specific haplotypes in APC and AXIN2 (P ≤ 0.03) and breast cancer risk. Further characterization of the APC and AXIN2 variants suggested that AXIN2 rs4791171 was significantly associated with risk in premenopausal (Ptrend = 0.0002) but not in postmenopausal women. The combination of our findings and numerous genetic and functional studies showing that APC and AXIN2 perform crucial tumor suppressor functions suggest that further investigation of the contribution of AXIN2 and APC SNPs to breast cancer risk are needed.",
author = "Xianshu Wang and Goode, {Ellen L} and Fredericksen, {Zachary S.} and Vierkant, {Robert A.} and Pankratz, {V. Shane} and Wen Liu-Mares and Rider, {David N.} and Vachon, {Celine M} and Cerhan, {James R} and Olson, {Janet E} and Couch, {Fergus J}",
year = "2008",
month = "8",
doi = "10.1158/1055-9965.EPI-08-0134",
language = "English (US)",
volume = "17",
pages = "2101--2108",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Association of genetic variation in genes implicated in the β-catenin destruction complex with risk of breast cancer

AU - Wang, Xianshu

AU - Goode, Ellen L

AU - Fredericksen, Zachary S.

AU - Vierkant, Robert A.

AU - Pankratz, V. Shane

AU - Liu-Mares, Wen

AU - Rider, David N.

AU - Vachon, Celine M

AU - Cerhan, James R

AU - Olson, Janet E

AU - Couch, Fergus J

PY - 2008/8

Y1 - 2008/8

N2 - Aberrant Wnt/β-catenin signaling leading to nuclear accumulation of the oncogene product β-catenin is observed in a wide spectrum of human malignancies. The destruction complex in the Wnt/β-catenin pathway is critical for regulating the level of β-catenin in the cytoplasm and in the nucleus. Here, we report a comprehensive study of the contribution of genetic variation in six genes encoding the β-catenin destruction complex (APC, AXIN1, AXIN2, CSNK1D, CSNK1E, and GSK3B) to breast cancer using a Mayo Clinic Breast Cancer Case-Control Study. A total of 79 candidate functional and tagging single nucleotide polymorphisms (SNP) were genotyped in 798 invasive cases and 843 unaffected controls. Of these, rs454886 in the APC tumor suppressor gene was associated with increased breast cancer risk (per allele odds ratio, 1.23; 95% confidence intervals, 1.05-1.43; Ptrend = 0.01). In addition, five SNPs in AXIN2 were associated with increased risk of breast cancer (P trend < 0.05). Haplotype-based tests identified significant associations between specific haplotypes in APC and AXIN2 (P ≤ 0.03) and breast cancer risk. Further characterization of the APC and AXIN2 variants suggested that AXIN2 rs4791171 was significantly associated with risk in premenopausal (Ptrend = 0.0002) but not in postmenopausal women. The combination of our findings and numerous genetic and functional studies showing that APC and AXIN2 perform crucial tumor suppressor functions suggest that further investigation of the contribution of AXIN2 and APC SNPs to breast cancer risk are needed.

AB - Aberrant Wnt/β-catenin signaling leading to nuclear accumulation of the oncogene product β-catenin is observed in a wide spectrum of human malignancies. The destruction complex in the Wnt/β-catenin pathway is critical for regulating the level of β-catenin in the cytoplasm and in the nucleus. Here, we report a comprehensive study of the contribution of genetic variation in six genes encoding the β-catenin destruction complex (APC, AXIN1, AXIN2, CSNK1D, CSNK1E, and GSK3B) to breast cancer using a Mayo Clinic Breast Cancer Case-Control Study. A total of 79 candidate functional and tagging single nucleotide polymorphisms (SNP) were genotyped in 798 invasive cases and 843 unaffected controls. Of these, rs454886 in the APC tumor suppressor gene was associated with increased breast cancer risk (per allele odds ratio, 1.23; 95% confidence intervals, 1.05-1.43; Ptrend = 0.01). In addition, five SNPs in AXIN2 were associated with increased risk of breast cancer (P trend < 0.05). Haplotype-based tests identified significant associations between specific haplotypes in APC and AXIN2 (P ≤ 0.03) and breast cancer risk. Further characterization of the APC and AXIN2 variants suggested that AXIN2 rs4791171 was significantly associated with risk in premenopausal (Ptrend = 0.0002) but not in postmenopausal women. The combination of our findings and numerous genetic and functional studies showing that APC and AXIN2 perform crucial tumor suppressor functions suggest that further investigation of the contribution of AXIN2 and APC SNPs to breast cancer risk are needed.

UR - http://www.scopus.com/inward/record.url?scp=54049127029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049127029&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-08-0134

DO - 10.1158/1055-9965.EPI-08-0134

M3 - Article

C2 - 18708403

AN - SCOPUS:54049127029

VL - 17

SP - 2101

EP - 2108

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 8

ER -